Clinical trial
Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL
NCT00355472 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00355472 |
|---|---|
| Title | Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL |
| Official title | Phase I Dose Escalation Study of KW-0761 in Patients With Relapsed Adult T-Cell Lymphoma (ATL) and Peripheral T-Cell Lymphoma (PTCL) |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adult T-Cell Leukemia and Lymphoma (ATL), Adult Peripheral T-Cell Lymphoma (PTCL) |
| Intervention type | Drug |
| Interventions | KW-0761 |
| Enrollment | 16 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 24, 2006 |
| Last update posted | Oct 18, 2012 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: